Related Experiment Video
Updated: Feb 15, 2026

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis
Published on: November 18, 2019
Quantitative proteomics reveals that miR-222 inhibits erythroid differentiation by targeting BLVRA and CRKL
Li Jiang1, Xing Wang1, Yong Wang1
1Medical Research Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Abstract:
miR-222 plays an important role in erythroid differentiation, but the potential targets of miR-222 in the regulation of erythroid differentiation remain to be determined. The target genes of miR-222 were identified by proteomics combined with bioinformatics analysis in this study. Thirteen proteins were upregulated, and 13 were downregulated in K562 cells following transfection with miR-222 inhibitor for 24 and 48 hours. Among these proteins, BLVRA and CRKL were upregulated after transfection of miR-222 inhibitor in K562 cells and human CD34+ HPCs. Moreover, miR-222 mimics reduced and miR-222 inhibitor enhanced the mRNA and protein levels of both BLVRA and CRKL. Luciferase assay showed that miR-222 directly targeted 3'-UTR of BLVRA and CRKL. In addition, overexpression of either BLVRA or CRKL or both increased the erythroid differentiation of K562 cells, while silencing of either BLVRA or CRKL or both by siRNA significantly attenuated hemin-induced erythroid differentiation of K562 cells. Our results indicated that BLVRA and CRKL are targets of miR-222.
Insights
MicroRNA-222 (miR-222) regulates red blood cell development by targeting BLVRA and CRKL. Inhibiting miR-222 increases BLVRA and CRKL, promoting erythroid differentiation.
Area of Science:
- Molecular Biology
- Hematology
- Gene Regulation
Background:
- MicroRNA-222 (miR-222) is implicated in erythroid differentiation.
- The specific molecular targets of miR-222 in this process are not fully understood.
Purpose of the Study:
- To identify and validate the direct targets of miR-222 involved in erythroid differentiation.
- To elucidate the regulatory mechanism of miR-222 in K562 cells and human CD34+ HPCs.
Main Methods:
- Proteomics and bioinformatics analysis to identify potential miR-222 targets.
- Transfection with miR-222 mimics and inhibitors in K562 cells and CD34+ HPCs.
- Luciferase assays, Western blotting, and siRNA-mediated gene silencing.
Main Results:
- BLVRA and CRKL were identified as upregulated targets of miR-222 inhibition.
- miR-222 directly targets the 3'-UTR of BLVRA and CRKL mRNA.
- Overexpression of BLVRA/CRKL enhanced erythroid differentiation, while silencing attenuated it.
Conclusions:
- BLVRA and CRKL are direct targets of miR-222.
- miR-222 regulates erythroid differentiation through the modulation of BLVRA and CRKL expression.
Related Concept Videos
Feedback Inhibition
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Enzyme Inhibition
Inhibition of Cdk Activity
Implicit Differentiation
Logarithmic Differentiation

